Cart
Free US shipping over $10
Proud to be B-Corp

Single-Arm Phase II Survival Trial Design Jianrong Wu

Single-Arm Phase II Survival Trial Design By Jianrong Wu

Single-Arm Phase II Survival Trial Design by Jianrong Wu


$256,39
Condition - New
Only 2 left

Summary

Single-arm phase II trial is a key component for developing advanced cancer drug and treatment to target therapy and immunotherapy in which time-to-event endpoints are the primary endpoints. The proposed book provides a comprehensive summary to the most commonly used methods for single-arm phase II trial design with time-to-event endpoints.

Single-Arm Phase II Survival Trial Design Summary

Single-Arm Phase II Survival Trial Design by Jianrong Wu

Single-Arm Phase II Survival Trial Design provides a comprehensive summary to the most commonly- used methods for single-arm phase II trial design with time-to-event endpoints. Single-arm phase II trials are a key component for successfully developing advanced cancer drugs and treatments, particular for target therapy and immunotherapy in which time-to-event endpoints are often the primary endpoints. Most test statistics for single-arm phase II trial design with time-to-event endpoints are not available in commercial software.

Key Features:

  • Covers the most frequently used methods for single-arm phase II trial design with time-to-event endpoints in a comprehensive fashion.
  • Provides new material on phase II immunotherapy trial design and phase II trial design with TTP ratio endpoint.
  • Illustrates trial designs by real clinical trial examples
  • Includes R code for all methods proposed in the book, enabling straightforward sample size calculation.

Single-Arm Phase II Survival Trial Design Reviews

"I would say it is a great book, great summary of not so common and widely available methods, focusing for a statistical audience with strong statistical skills."

David Manteigas, Portugal, ISCB News, June 2022.

About Jianrong Wu

Jianrong (John) Wu is a professor in the Division of Cancer Biostatistics, Department of Internal Medicine, University of Kentucky; Biostatistics and Bioinformatics Shared Resource, Markey Cancer Center. Dr. Wu has more than 20 years experience of designing and conducting cancer clinical trials at St. Jude Childrens Research Hospital and Markey Cancer Center and has developed many novel statistical methods for designing and monitoring single-arm phase II and randomized phase III trial design with time-to-event endpoints.

Table of Contents

1. Introduction of Single-Arm Phase II Trial Design
2. Phase II Trial Design Under Parametric Model
3. One-Stage Design Evaluating Survival Probabilities
4. Two-Stage Design Evaluating Survival Probabilities
5. One-Stage Design Evaluating Survival Distributions
6. Two-Stage Design Evaluating Survival Distributions
7. Phase II Immunotherapy Trial Design
8. Phase II Trial Design with GMI Endpoint
9. Bayesian Single-Arm Phase II Trial Design
Appendix A. Probability of Failure Under Uniform Accrual
Appendix B. Asymptotic Distribution of Nelson-Aalen Estimate of the Cumulative Hazard
Appendix C. Derivation Asymptotic Distribution of the OSLRT
Appendix D. Derivation of equations (6.8) and (6.9)
Appendix E. Crossing point for the mixture cure model
Appendix F. Derivation asymptotic distribution of the score test Q
Appendix G. Generate random variables from GBVE model
Appendix H. Derivation censoring survival distribution of GMI
Appendix I. Proof of monotonicity of the posterior probability
Appendix J. Relationship between frequentist and Bayesian type I error rates
Appendix K. R Code

Additional information

NPB9780367653453
9780367653453
0367653451
Single-Arm Phase II Survival Trial Design by Jianrong Wu
New
Hardback
Taylor & Francis Ltd
2021-07-20
263
N/A
Book picture is for illustrative purposes only, actual binding, cover or edition may vary.
This is a new book - be the first to read this copy. With untouched pages and a perfect binding, your brand new copy is ready to be opened for the first time

Customer Reviews - Single-Arm Phase II Survival Trial Design